Levocetirizine: a modern H₁-antihistamine for the treatment of allergic rhinitis

References

• Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur. Respir. J. 24, 758–764 (2004).
   PubMed Web of Science ®Google Scholar
• Lundbäck B. Epidemiology of rhinitis and asthma. Clin. Exp. Allergy 28(Suppl. 2), 3–10 (1998).
   PubMed Web of Science ®Google Scholar
• Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J. Allergy Clin. Immunol. 106(Suppl. 5), S201–S205 (2000).
   Web of Science ®Google Scholar
• Baroody FM. Allergic rhinitis: broader disease effects and implications for management. Otolaryngol. Head Neck Surg. 128, 616–631 (2003).
   PubMed Web of Science ®Google Scholar
• Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis. Pharmacoeconomics 22, 345–361 (2004).
   PubMed Web of Science ®Google Scholar
• Bachert C. The role of histamine in allergic disease: re-appraisal of its inflammatory potential. Allergy 57, 287–296 (2002).
   PubMed Web of Science ®Google Scholar
• Scannell RT, Differding E, Talaga P. Dual acting antihistaminergic agents. Mini Rev. Med. Chem. 4, 923–933 (2004).
   PubMed Web of Science ®Google Scholar
• Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin. Exp. Allergy 32, 489–498 (2002).
   PubMed Web of Science ®Google Scholar
• Simons FE. H1-antihistamines: more relevant than ever in the treatment of allergic disorders. J. Allergy Clin. Immunol. 112(4 Suppl.), 42–52 (2003).
   PubMed Web of Science ®Google Scholar
• Holgate ST, Canonica GW, Simons FE et al. Consensus Group on New-Generation Antihistamines. (CONGA): present status and recommendations. Clin. Exp. Allergy 33, 1305–1324 (2003).
   PubMed Web of Science ®Google Scholar
• Bousquet J, van Cauwenberge P, Khaltaev N, ARIA Workshop Group. Allergic Rhinitis and its Impact on Asthma (ARIA). J. Allergy Clin. Immunol. 108(Suppl. 5), S147–S333 (2001).
   PubMed Web of Science ®Google Scholar
• Van Cauwenberge P, Bachert C, Passalacqua G et al. Consensus statement on the treatment of allergic rhinitis. Allergy 55, 116–134 (2000).
   PubMed Web of Science ®Google Scholar
• Kay GG. The effects of antihistamines on cognition and performance. J. Allergy Clin. Immunol. 105, S622–S627 (2000).
   Google Scholar
• Simons FER. H1-antihistamines in children. Clin. Allergy Immunol. 17, 437–464 (2002).
   PubMedGoogle Scholar
• Gelfand EW, Plaut M, Washington T et al. Current trends in allergic reactions: A multidisciplinary approach to patient management. Inter. Med. 5(1), 1–12 (2003).
   Google Scholar
• Hore I, Georgalas C, Scadding G. Oral antihistamines for the symptom of nasal obstruction in persistent allergic rhinitis - a systematic review of randomized controlled trials. Clin. Exp. Allergy 35, 207–212 (2005).
   PubMedGoogle Scholar
• Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J. Allergy Clin. Immunol. 113, 415–419 (2004).
   PubMed Web of Science ®Google Scholar
• Nelson HS. Prospects for antihistamines in the treatment of asthma. J. Allergy Clin. Immunol. 112(4 Suppl.), S96–S100 (2003).
   Google Scholar
• Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J. Allergy Clin. Immunol. 109, 636–642 (2002).
   PubMed Web of Science ®Google Scholar
• Strolin Benedetti M, Plisnier M, Kaise J et al. Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers. Eur. J. Clin. Pharmacol. 57, 571–582 (2001).
   PubMedGoogle Scholar
• Simons FER. Population pharmacokinetics of levocetirizine in very young children: the paediatrician’s perspective. Pediatr. Allergy Immunol. 16, 97–103 (2005).
   PubMed Web of Science ®Google Scholar
• Hussein Z, Pitsiu M, Majid O, Aarons L, de Longueville M, Stokis A. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC® study. Br. J. Clin. Pharmacol. 59, 28–37 (2005).
   PubMed Web of Science ®Google Scholar
• Cranswick N, Turzíková J, Fuchs M, Hulhoven R. Levocetirizine in 1 to 2 year old children: pharmacokinetic and pharmacodynamic profile. Int. J. Clin. Pharm. Ther. 43, 172–177 (2005).
   PubMed Web of Science ®Google Scholar
• Baltes E, Coupez R, Giezek H, Voss G, Meyerhoff C, Strolin Benedetti M. Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam. Clin. Pharmacol. 15, 269–277 (2001).
   PubMed Web of Science ®Google Scholar
• Molimard M, Diquet B, Benedetti M. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam. Clin. Pharmacol. 18, 399–411 (2004).
   PubMed Web of Science ®Google Scholar
• Tillement J-P, Albengres E, Barré J et al. The apparent volumes of distribution of H1-receptor antagonists. Dermatol. Ther. 13, 337–343 (2000).
   Google Scholar
• Gillard M, Van Der Perren C, Massingham R, Chatelain P. Binding characteristics of [3H] levocetirizine to cloned human H1-histamine receptors expressed in CHO cells. Inflamm. Res. 51(Suppl. 1), S77–S78 (2002).
   Google Scholar
• Gillard M, Van Der Perren C, Moguilevsky N, Massingham R, Chatelain P. Major role for the carboxylic function of cetirizine and levocetirizine to their binding characteristics to human H1-histamine receptors. Inflamm. Res. 51(Suppl.1), S79–S80 (2002).
   PubMedGoogle Scholar
• Gillard M, Christophe B, Wels B, Peck M, Massingham R, Chatelain P. H1 antagonists. Receptor affinity versus selectivity. Inflamm. Res. 52(Suppl. 1), S49–S50 (2003).
   PubMed Web of Science ®Google Scholar
• Strolin Benedetti M, Gillard M, Chatelain P, Baltes E, De Vos C. An integrated comparison of the pharmacological, pharmacokinetic and pharmacodynamic characteristics of the new second generation H1-antihistamines. Allergy Clin. Immunol. Int. S1, 270–345 (2005).
   Google Scholar
• Devalia JL, De Vos C, Hanotte F, Baltes E. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 56, 50–57 (2001).
   PubMedGoogle Scholar
• Clough GF, Boutsiouki P, Church MK. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy 56, 985–988 (2001).
   PubMedGoogle Scholar
• Hindmarch I, Johnson S, Meadows R, Kirkpatric T, Shamsi Z. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and wheal and flare. Curr. Med. Res. Opin. 17, 241–255 (2001).
   PubMed Web of Science ®Google Scholar
• Grant JA, Riethuisen J-M, Moulaert B, De Vos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann. Allergy Asthma Immunol. 88, 190–197 (2002).
   PubMed Web of Science ®Google Scholar
• Purohit A, Melac M, Pauli G, Frossard N. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Br. J. Clin. Pharmacol. 56, 388–394 (2003).
   PubMed Web of Science ®Google Scholar
• Denham KJ, Boutsiouki P, Clough GF, Church MK. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Inflamm. Res. 52, 424–427 (2003).
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Guerra L, Compalati E et al. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours. Int. Arch. Allergy Immunol. 135, 143–147 (2004).
   Google Scholar
• Frossard N, Purohit A, Becker J, Pauli G. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine: a double-blind placebo-controlled study. EADV (2005). Abstract.
   Google Scholar
• Wang DY, Hanotte F, De Vos C, Clement P. Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers. Allergy 56, 339–343 (2001).
   Google Scholar
• Larbig M, Stamm H, Hohlfeld J, Krug N. Levocetirizine but not desloratadine inhibits histamine-induced changes in nasal temperature measured by facial thermography: a pilot study. Allergy 58, 982 (2003) (Abstract).
   Google Scholar
• Larbig M, Stamm H, Casper A, Hohlfeld J, Krug N. Twenty-four hour anti-H1 activity of levocetirizine measured by thermography is superior to fexofenadine. EAACI (2004) (Abstract).
   Google Scholar
• Assanasen P, Naclerio RM. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin. Allergy Immunol. 17, 101–139 (2002).
   PubMedGoogle Scholar
• Ying S, Meng Q, Kay AB. The effect of levocetirizine on histamine and cytokine-induced upregulation of eotaxin by endothelial cells. Allergy 57 (S73), 442 (2002) (Abstract).
   PubMedGoogle Scholar
• Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G. H1 histamine receptor mediates inflammatory responses in human keratinocytes. Allergy Clin. Immunol. 114, 1176–1182 (2004).
   Google Scholar
• Pellet C, Jean-Louis F, Boland S, Dubertret L, Michel L. Levocetirizine decreases VCAM-1 expression induced by TNF-alpha in human dermal endothelial cells through down-regulation of NF-kappaB pathway. 2004 (Abstract).
   Google Scholar
• Michel L, Jean-Louis F, Boland S, Pellet C, Dubertret L. Inhibition by levocetirizine of VCAM-1 production in human dermal endothelial cells in vitro blockage of NF-κB and possible mechanism of antiallergic action. Allergy 58, 1061 (2003)(Abstract).
   Google Scholar
• Jazrawi E, Stirling R, Chung F. Effects of levocetirizine in an in-vitro model of eosinophil chemotaxis induced by eotaxin. Allergy 56 (S68), 415 (2001) (Abstract).
   Google Scholar
• Thomson L, Blaylock MG, Sexton DW, Campbell A, Walsh GM. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin. Exp Allergy. 32, 1187–1192 (2002).
   PubMed Web of Science ®Google Scholar
• Petecchia L, Serpero L, Silvestri M, Sabatini F, Scarso L, Rossi GA. Downregulation of vascular adhesion molecule (VCAM)-1 expression by nasal fibroblasts by levocetirizine in vitro. Eur. Respir. J. 24(Suppl. 48), 129s (2004).
   PubMedGoogle Scholar
• Gutzmer R, Wittmann M, Kapp A, Werfel T. Direct immunomodulatory effects of levocetirizine on lymphocytes. Allergy 58, 1060 (2003) (Abstract).
   Google Scholar
• Werfel T, Wittmann M, Kapp A. Influence of levocetirizine (LC) on lymphocytes. Allergy Clin. Immunol. Int. S1, P21–P26 (2003).
   Google Scholar
• Michel L, Jean-Louis F, Dubertret L. Pharmacological study of levocetirizine in IgE-dependent hypersensitivity cutaneous reaction in grass pollen allergic volunteers : demonstration of mediator release and eosinophil recruitment modulation by levocetirizine. Allergy 56(S68), 458 (2001)(Abstract).
   Google Scholar
• Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin. Exp. Allergy 34, 958–964 (2004).
   PubMed Web of Science ®Google Scholar
• Dykewicz MS, Fineman S, Skoner DP et al. Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology. Ann. Allergy Asthma Immunol. 81, 478–518 (1998).
   PubMed Web of Science ®Google Scholar
• Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J. Allergy Clin. Immunol. 108(1 Suppl. 1), S2–S8 (2001).
   PubMed Web of Science ®Google Scholar
• Leynadier F, Mees K, Arendt C, Pinelli ME. Efficacy and safety of levocetirizine in seasonal allergic rhinitis. Acta. Otorhinolaryngol. Belg. 55, 305–312 (2001).
   PubMedGoogle Scholar
• de Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a six-week, randomised seasonal allergic rhinitis trial. Pediatr. Allergy Immunol. 16, 267–275 (2005).
   PubMed Web of Science ®Google Scholar
• Stübner P, Zieglmayer R, Horak F. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomized, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit – the Vienna Challenge Chamber (VCC). Curr. Med. Res. Opin. 20, 891–902 (2004).
   PubMed Web of Science ®Google Scholar
• Horak F, Stübner PU, Zieglmayer R, Kavina A, Lemel P. Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. Br. J. Clin. Pharmacol. 60, 24–31 (2005).
   Google Scholar
• Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative clinical efficacy, onset and duration of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Int. J. Clin. Pract. 58, 109–118 (2004).
   PubMed Web of Science ®Google Scholar
• Deruaz C, Leimgruber A, Berney M et al. Levocetirizine better protects than desloratadine in a nasal provocation with allergen. J. Allery Clin. Immunol. 113, 669–676 (2004).
   PubMed Web of Science ®Google Scholar
• Potter PC. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 58, 893–899 (2003).
   PubMed Web of Science ®Google Scholar
• Potter PC. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double blind placebo controlled randomized clinical trial. Ann. Allergy Asthma Immunol. (2005) (In press).
   Google Scholar
• Didier A. Efficacy of levocetirizine in perennial allergic rhinitis (PAR) as measured by the number of comfortable days. Eur. Respir. J. 24(S48), 124S (2004).
   Google Scholar
• Demoly P, Allaert F-A, Lecasble M, Bousquet J, PRAGMA. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma) Allergy 58, 672–675 (2003).
   PubMed Web of Science ®Google Scholar
• Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 60, 350–353 (2005).
   PubMed Web of Science ®Google Scholar
• Bachert C, Bousquet J, Canonica GW et al. Levocetirizine improves quality of life and reduces costs in long-term treatment of persistent allergic rhinitis. J. Allery Clin. Immunol. 114, 838–844 (2004).
   Google Scholar
• Canonica GW, Bousquet J, Van Hammée G et al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Ann. Allergy Asthma Immunol. 27, 979–992 (2005).
   Google Scholar
• Ciprandi G, Cirillo IG, Vizzaccaro A, Tosca MA. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study. Eur. Ann. Allergy Clin. Immunol. Allerg. Immunol. 37, 25–29 (2005).
   PubMedGoogle Scholar
• Bachert C, Demarteau N. Levocetirizine reduces asthma comorbidity in patients with persistent allergic rhinitis: an exploratory analysis of the XPERT™ trial. Allergy Clin. Immunol. Int. S1, 100–101 (2005).
   Google Scholar
• Bousquet J, Demarteau N, Mullol J et al. Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 60, 788–794 (2005).
   PubMed Web of Science ®Google Scholar
• Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br. J. Clin. Pharmacol. 54, 51–58 (2002).
   PubMed Web of Science ®Google Scholar
• Verster JC, Volkerts ER, van Oosterwijck AW et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J. Allery Clin. Immunol. 111, 623–627 (2003).
   Google Scholar
• Verster JC, de Weert AM, Bijtjes SI et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology 169, 84–90 (2003).
   PubMed Web of Science ®Google Scholar
• Data on file, UCB Farchim S.A.
   Google Scholar
• Klimek L, Hundorf I. Levocetirizine in allergic diseases: an open multicentre practice study of efficacy and tolerability. Allergologie 25(Suppl. 1), S1–S7 (2002).
   Google Scholar
• Jorissen M, Hellings PW. Levocetirizine is a highly effective treatment of seasonal allergic rhinitis: An open multicentre study in Belgium (Xpoll). Allergy Clin. Immunol. Int. S1, 270 (2005).
   Google Scholar
• Layton D, Wilton LV, Shakir SAW. Safety profile of levocetirizine as used in general practice in England: Results of a prescription-event monitoring study (209). Pharmacoepid. Drug Safety 13, S112 (2004).
   Google Scholar